Cambridgeshire, United Kingdom

Susanna Del Rio Gancedo

This inventor holds 1 USPTO granted patent. Top assignees: Intellikine LLC, Sigma-Aldrich Co. LLC. Active years: 2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Susanna Del Rio Gancedo. Retrieved from https://idiyas.com/inventor/susanna-del-rio-gancedo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2016

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Susanna Del Rio Gancedo: Innovator in Kinase Inhibition

Introduction

Susanna Del Rio Gancedo is a prominent inventor based in Cambridgeshire, GB. She has made significant contributions to the field of pharmaceutical sciences, particularly in the development of kinase inhibitors. Her work focuses on modulating kinase activity, which is crucial for various biological processes.

Latest Patents

Susanna holds a patent for "Kinase inhibitor polymorphs." This patent describes polymorphs of chemical compounds that modulate kinase activity, including PI3K activity. The patent also covers pharmaceutical compositions and methods of treatment for diseases associated with kinase activity, including those related to PI3K.

Career Highlights

Throughout her career, Susanna has worked with notable companies such as Intellikine LLC and Sigma-Aldrich Co. LLC. Her expertise in the field has allowed her to contribute to innovative solutions in drug development and therapeutic applications.

Collaborations

Some of her notable coworkers include Pingda Ren and Michael Martin. Their collaborative efforts have further advanced the research and development of kinase inhibitors.

Conclusion

Susanna Del Rio Gancedo's work in kinase inhibition represents a significant advancement in pharmaceutical research. Her contributions continue to impact the field and pave the way for future innovations in treatment methodologies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…